Stay updated on Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for this Phase 2 study is displayed, including its recruitment status, treatment plan, eligibility criteria, locations, and outcome measures. Previously, the page showed a 403 Forbidden error.
    Difference
    59%
    Check dated 2026-11-11T02:11:04.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-11-04T00:53:07.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces NIH's terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. The site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:50:47.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:54:51.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of showing the study record content, indicating a permissions issue on the page.
    Difference
    20%
    Check dated 2026-09-23T01:04:15.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page revision identifier was updated from v3.6.6 to v3.7.0, indicating a refresh of the page content or layout without changing the underlying study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:13:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.